Effectiveness of transdiagnostic treatment on psychological parameters in multiple sclerosis

Phase 2

• Conditions: Multiple Sclerosis.; Multiple sclerosis

• Registration Number: IRCT20221230056986N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Confirmation of relapsing-remitting multiple sclerosis diagnosis by neurologist
Age least 20 years
Being sexually active
Mastery in Persian language and reading and writing literacy
Fixed dosage of medicine from 3 months before beginning the treatment
Being physically able to participate in weekly sessions
Not being diagnosed with severe psychiatric disorders
Not being diagnosed with another serious or chronic physical illness
Not having the history of receiving psychological treatments

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psychological symptoms. Timepoint: Before intervention, after intervention, three month after intervention. Method of measurement: Depression, Anxiety, Stress Scale (DASS-21).;Fatigue. Timepoint: Before intervention, after intervention, three month after intervention. Method of measurement: Fatigue Severity Scale (FSS).;Quality of sleep. Timepoint: Before intervention, after intervention, three month after intervention. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).;Sexual Satisfaction. Timepoint: Before intervention, after intervention, three month after intervention. Method of measurement: Larson Sexual Satisfaction Questionnaire (LSSQ).;Emotion regulation. Timepoint: Before intervention, after intervention, three month after intervention. Method of measurement: Cognitive Emotion Regulation Questionnaire (SERQ).;Health anxiety. Timepoint: Before intervention, after intervention, three month after intervention. Method of measurement: Health Anxiety Questionnaire (HAQ).